Sickle Cell Disease
Last Posted: Sep 21, 2023
- Gene therapy for Hemoglobinopathies.
Maria Rosa Lidonnici et al. Hum Gene Ther 2023
- Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis.
Joshua C Combs et al. F S Rep 2023 4(3) 300-307
- Pregnant and Living with Sickle Cell Disease: A Push for Better Outcomes
NIH, September 2023
- Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019.
Roseli Divino Costa et al. Rev Paul Pediatr 2023 42e2022161
- A Proclamation on National Sickle Cell Awareness Month, 2023
The White House, September 2023.
- CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
Akshay Sharma et al. N Engl J Med 2023 8 (9) 820-832
- Newborn screening for sickle cell disease in Butembo and Beni: a pilot experience in a highland region of the Democratic Republic of Congo.
Mupenzi Mumbere et al. Pan Afr Med J 2023 4556
- Sickle cell disease in Ontario, Canada: an epidemiologic profile based on health administrative data.
Jacob Pendergrast et al. CMAJ Open 2023 11(4) E725-E733
- Genetic counseling in sickle cell disease: Insights from the Indian tribal population.
Pooja Aggarwal et al. J Community Genet 2023 8
- Spreading awareness of sickle cell trait and its possible complications A better understanding of the trait is crucial for both patients and providers
M Shaniqua, Sickle Cell New, August 2023
- Barriers and Facilitators of Premarital Genetic Counseling for Sickle Cell Disease in Northern Nigeria.
Aisha A Galadanci et al. J Pediatr Hematol Oncol 2023 45(6) e716-e722
- Base-edited gene therapies ‘may be superior’ for sickle cell disease
Healio, July 2023
- Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
Frédéric B Piel et al. Lancet Haematol 2023
- Sickle cell disease in the Caribbean: progress in newborn screening, clinical care, and research through collaboration.
Jennifer Knight-Madden et al. Lancet Haematol 2023
- Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective.
María Del Mar Mañú Pereira et al. Lancet Haematol 2023
- The Importance of Patient-Doctor Relationships With Sickle Cell Disease
L Poret, WebMD, July 2023
- Sickle cell cures are coming. African children can’t be left behind
JK Iyer, Statnews, July 2023
- Ending the burden of sickle cell disease in Africa
MR Motti et al, Lancet Hematology, July 2023
- Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.
et al. Lancet Haematol 2023 6
- Social determinants of health: the next frontier for improving care and outcomes in sickle cell disease
JS Porter et al, Lancet Heamtology, July 2023
- The Lancet Haematology Commission on sickle cell disease: key recommendations
The Lancet Haematology Commission on sickle cell disease: Lancet Hematology, July 2023
- School and Sickle Cell Disease: Lessons I Had to Unlearn
DN Wilson, WebMD, July 2023
- Screening during IVF for inherited diseases can greatly reduce costs of care
L Flynn, MedicalXpress, July 2023
- Potent and uniform fetal hemoglobin induction via base editing.
Thiyagaraj Mayuranathan et al. Nat Genet 2023 7
- Clinical Profiles of Children With Sickle Cell Anaemia Presenting With Acute Clinical Events: A Single-Center Study.
Anwesha Singh et al. Cureus 2023 15(5) e39008
- Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.
Ashima Singh et al. JMIR Public Health Surveill 2023 9e42816
- The Role of Hyposthenuria in Enuresis Among Paediatric Patients With Sickle Cell Disease.
Jasim N Al-Asadi et al. Sultan Qaboos Univ Med J 2023 23(2) 206-211
- Base editing shows potential superiority for curing sickle cell disease
Medical XPress, June 29, 2023
- Why we need more Black blood donors to treat sickle cell anemia
SB Peter, CNN, June 27, 2023
- Suddenly, It Looks Like We’re in a Golden Age for Medicine We may be on the cusp of an era of astonishing innovation — the limits of which aren’t even clear yet.
DW Wells, New York Times. June 23, 2023
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Common HLBS Health Categories
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.